The global Endoparasiticide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Endoparasiticide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Endoparasiticide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Endoparasiticide include Boehringer Ingelheim, Elanco, Zoetis, Merck, Virbac, Novartis AG, Ceva Sante Animlae, Bayer AG and Eli Lilly, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Endoparasiticide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endoparasiticide.

Report Scope

The Endoparasiticide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Endoparasiticide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Endoparasiticide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Endoparasiticide Market Report

Report Metric	Details
Report Name	Endoparasiticide Market
Segment by Type	Ear Tags Tablets Injectables Feed Additives
Segment by Application	Veterinary Hospitals or Clinics Animal Farms Home Care Settings
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Boehringer Ingelheim, Elanco, Zoetis, Merck, Virbac, Novartis AG, Ceva Sante Animlae, Bayer AG, Eli Lilly, Vetoquinol
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Endoparasiticide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Endoparasiticide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Endoparasiticide Market report?

Ans: The main players in the Endoparasiticide Market are Boehringer Ingelheim, Elanco, Zoetis, Merck, Virbac, Novartis AG, Ceva Sante Animlae, Bayer AG, Eli Lilly, Vetoquinol

What are the Application segmentation covered in the Endoparasiticide Market report?

Ans: The Applications covered in the Endoparasiticide Market report are Veterinary Hospitals or Clinics, Animal Farms, Home Care Settings

What are the Type segmentation covered in the Endoparasiticide Market report?

Ans: The Types covered in the Endoparasiticide Market report are Ear Tags, Tablets, Injectables, Feed Additives

1 Endoparasiticide Market Overview

1.1 Product Overview and Scope of Endoparasiticide

1.2 Endoparasiticide Segment by Type

1.2.1 Global Endoparasiticide Market Value Comparison by Type (2024-2030)

1.2.2 Ear Tags

1.2.3 Tablets

1.2.4 Injectables

1.2.5 Feed Additives

1.3 Endoparasiticide Segment by Application

1.3.1 Global Endoparasiticide Market Value by Application: (2024-2030)

1.3.2 Veterinary Hospitals or Clinics

1.3.3 Animal Farms

1.3.4 Home Care Settings

1.4 Global Endoparasiticide Market Size Estimates and Forecasts

1.4.1 Global Endoparasiticide Revenue 2019-2030

1.4.2 Global Endoparasiticide Sales 2019-2030

1.4.3 Global Endoparasiticide Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Endoparasiticide Market Competition by Manufacturers

2.1 Global Endoparasiticide Sales Market Share by Manufacturers (2019-2024)

2.2 Global Endoparasiticide Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Endoparasiticide Average Price by Manufacturers (2019-2024)

2.4 Global Endoparasiticide Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Endoparasiticide, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Endoparasiticide, Product Type & Application

2.7 Endoparasiticide Market Competitive Situation and Trends

2.7.1 Endoparasiticide Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Endoparasiticide Players Market Share by Revenue

2.7.3 Global Endoparasiticide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Endoparasiticide Retrospective Market Scenario by Region

3.1 Global Endoparasiticide Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Endoparasiticide Global Endoparasiticide Sales by Region: 2019-2030

3.2.1 Global Endoparasiticide Sales by Region: 2019-2024

3.2.2 Global Endoparasiticide Sales by Region: 2025-2030

3.3 Global Endoparasiticide Global Endoparasiticide Revenue by Region: 2019-2030

3.3.1 Global Endoparasiticide Revenue by Region: 2019-2024

3.3.2 Global Endoparasiticide Revenue by Region: 2025-2030

3.4 North America Endoparasiticide Market Facts & Figures by Country

3.4.1 North America Endoparasiticide Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Endoparasiticide Sales by Country (2019-2030)

3.4.3 North America Endoparasiticide Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Endoparasiticide Market Facts & Figures by Country

3.5.1 Europe Endoparasiticide Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Endoparasiticide Sales by Country (2019-2030)

3.5.3 Europe Endoparasiticide Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Endoparasiticide Market Facts & Figures by Country

3.6.1 Asia Pacific Endoparasiticide Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Endoparasiticide Sales by Country (2019-2030)

3.6.3 Asia Pacific Endoparasiticide Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Endoparasiticide Market Facts & Figures by Country

3.7.1 Latin America Endoparasiticide Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Endoparasiticide Sales by Country (2019-2030)

3.7.3 Latin America Endoparasiticide Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Endoparasiticide Market Facts & Figures by Country

3.8.1 Middle East and Africa Endoparasiticide Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Endoparasiticide Sales by Country (2019-2030)

3.8.3 Middle East and Africa Endoparasiticide Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Endoparasiticide Sales by Type (2019-2030)

4.1.1 Global Endoparasiticide Sales by Type (2019-2024)

4.1.2 Global Endoparasiticide Sales by Type (2025-2030)

4.1.3 Global Endoparasiticide Sales Market Share by Type (2019-2030)

4.2 Global Endoparasiticide Revenue by Type (2019-2030)

4.2.1 Global Endoparasiticide Revenue by Type (2019-2024)

4.2.2 Global Endoparasiticide Revenue by Type (2025-2030)

4.2.3 Global Endoparasiticide Revenue Market Share by Type (2019-2030)

4.3 Global Endoparasiticide Price by Type (2019-2030)

5 Segment by Application

5.1 Global Endoparasiticide Sales by Application (2019-2030)

5.1.1 Global Endoparasiticide Sales by Application (2019-2024)

5.1.2 Global Endoparasiticide Sales by Application (2025-2030)

5.1.3 Global Endoparasiticide Sales Market Share by Application (2019-2030)

5.2 Global Endoparasiticide Revenue by Application (2019-2030)

5.2.1 Global Endoparasiticide Revenue by Application (2019-2024)

5.2.2 Global Endoparasiticide Revenue by Application (2025-2030)

5.2.3 Global Endoparasiticide Revenue Market Share by Application (2019-2030)

5.3 Global Endoparasiticide Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Boehringer Ingelheim

6.1.1 Boehringer Ingelheim Corporation Information

6.1.2 Boehringer Ingelheim Description and Business Overview

6.1.3 Boehringer Ingelheim Endoparasiticide Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Boehringer Ingelheim Endoparasiticide Product Portfolio

6.1.5 Boehringer Ingelheim Recent Developments/Updates

6.2 Elanco

6.2.1 Elanco Corporation Information

6.2.2 Elanco Description and Business Overview

6.2.3 Elanco Endoparasiticide Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Elanco Endoparasiticide Product Portfolio

6.2.5 Elanco Recent Developments/Updates

6.3 Zoetis

6.3.1 Zoetis Corporation Information

6.3.2 Zoetis Description and Business Overview

6.3.3 Zoetis Endoparasiticide Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Zoetis Endoparasiticide Product Portfolio

6.3.5 Zoetis Recent Developments/Updates

6.4 Merck

6.4.1 Merck Corporation Information

6.4.2 Merck Description and Business Overview

6.4.3 Merck Endoparasiticide Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Merck Endoparasiticide Product Portfolio

6.4.5 Merck Recent Developments/Updates

6.5 Virbac

6.5.1 Virbac Corporation Information

6.5.2 Virbac Description and Business Overview

6.5.3 Virbac Endoparasiticide Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Virbac Endoparasiticide Product Portfolio

6.5.5 Virbac Recent Developments/Updates

6.6 Novartis AG

6.6.1 Novartis AG Corporation Information

6.6.2 Novartis AG Description and Business Overview

6.6.3 Novartis AG Endoparasiticide Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Novartis AG Endoparasiticide Product Portfolio

6.6.5 Novartis AG Recent Developments/Updates

6.7 Ceva Sante Animlae

6.6.1 Ceva Sante Animlae Corporation Information

6.6.2 Ceva Sante Animlae Description and Business Overview

6.6.3 Ceva Sante Animlae Endoparasiticide Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Ceva Sante Animlae Endoparasiticide Product Portfolio

6.7.5 Ceva Sante Animlae Recent Developments/Updates

6.8 Bayer AG

6.8.1 Bayer AG Corporation Information

6.8.2 Bayer AG Description and Business Overview

6.8.3 Bayer AG Endoparasiticide Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Bayer AG Endoparasiticide Product Portfolio

6.8.5 Bayer AG Recent Developments/Updates

6.9 Eli Lilly

6.9.1 Eli Lilly Corporation Information

6.9.2 Eli Lilly Description and Business Overview

6.9.3 Eli Lilly Endoparasiticide Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Eli Lilly Endoparasiticide Product Portfolio

6.9.5 Eli Lilly Recent Developments/Updates

6.10 Vetoquinol

6.10.1 Vetoquinol Corporation Information

6.10.2 Vetoquinol Description and Business Overview

6.10.3 Vetoquinol Endoparasiticide Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Vetoquinol Endoparasiticide Product Portfolio

6.10.5 Vetoquinol Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Endoparasiticide Industry Chain Analysis

7.2 Endoparasiticide Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Endoparasiticide Production Mode & Process

7.4 Endoparasiticide Sales and Marketing

7.4.1 Endoparasiticide Sales Channels

7.4.2 Endoparasiticide Distributors

7.5 Endoparasiticide Customers

8 Endoparasiticide Market Dynamics

8.1 Endoparasiticide Industry Trends

8.2 Endoparasiticide Market Drivers

8.3 Endoparasiticide Market Challenges

8.4 Endoparasiticide Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Endoparasiticide Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Endoparasiticide Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Endoparasiticide Market Competitive Situation by Manufacturers in 2023

Table 4. Global Endoparasiticide Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Endoparasiticide Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Endoparasiticide Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Endoparasiticide Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Endoparasiticide Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Endoparasiticide, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Endoparasiticide, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Endoparasiticide, Product Type & Application

Table 12. Global Key Manufacturers of Endoparasiticide, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Endoparasiticide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endoparasiticide as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Endoparasiticide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Endoparasiticide Sales by Region (2019-2024) & (K Units)

Table 18. Global Endoparasiticide Sales Market Share by Region (2019-2024)

Table 19. Global Endoparasiticide Sales by Region (2025-2030) & (K Units)

Table 20. Global Endoparasiticide Sales Market Share by Region (2025-2030)

Table 21. Global Endoparasiticide Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Endoparasiticide Revenue Market Share by Region (2019-2024)

Table 23. Global Endoparasiticide Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Endoparasiticide Revenue Market Share by Region (2025-2030)

Table 25. North America Endoparasiticide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Endoparasiticide Sales by Country (2019-2024) & (K Units)

Table 27. North America Endoparasiticide Sales by Country (2025-2030) & (K Units)

Table 28. North America Endoparasiticide Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Endoparasiticide Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Endoparasiticide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Endoparasiticide Sales by Country (2019-2024) & (K Units)

Table 32. Europe Endoparasiticide Sales by Country (2025-2030) & (K Units)

Table 33. Europe Endoparasiticide Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Endoparasiticide Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Endoparasiticide Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Endoparasiticide Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Endoparasiticide Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Endoparasiticide Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Endoparasiticide Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Endoparasiticide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Endoparasiticide Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Endoparasiticide Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Endoparasiticide Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Endoparasiticide Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Endoparasiticide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Endoparasiticide Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Endoparasiticide Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Endoparasiticide Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Endoparasiticide Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Endoparasiticide Sales (K Units) by Type (2019-2024)

Table 51. Global Endoparasiticide Sales (K Units) by Type (2025-2030)

Table 52. Global Endoparasiticide Sales Market Share by Type (2019-2024)

Table 53. Global Endoparasiticide Sales Market Share by Type (2025-2030)

Table 54. Global Endoparasiticide Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Endoparasiticide Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Endoparasiticide Revenue Market Share by Type (2019-2024)

Table 57. Global Endoparasiticide Revenue Market Share by Type (2025-2030)

Table 58. Global Endoparasiticide Price (US$/Unit) by Type (2019-2024)

Table 59. Global Endoparasiticide Price (US$/Unit) by Type (2025-2030)

Table 60. Global Endoparasiticide Sales (K Units) by Application (2019-2024)

Table 61. Global Endoparasiticide Sales (K Units) by Application (2025-2030)

Table 62. Global Endoparasiticide Sales Market Share by Application (2019-2024)

Table 63. Global Endoparasiticide Sales Market Share by Application (2025-2030)

Table 64. Global Endoparasiticide Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Endoparasiticide Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Endoparasiticide Revenue Market Share by Application (2019-2024)

Table 67. Global Endoparasiticide Revenue Market Share by Application (2025-2030)

Table 68. Global Endoparasiticide Price (US$/Unit) by Application (2019-2024)

Table 69. Global Endoparasiticide Price (US$/Unit) by Application (2025-2030)

Table 70. Boehringer Ingelheim Corporation Information

Table 71. Boehringer Ingelheim Description and Business Overview

Table 72. Boehringer Ingelheim Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Boehringer Ingelheim Endoparasiticide Product

Table 74. Boehringer Ingelheim Recent Developments/Updates

Table 75. Elanco Corporation Information

Table 76. Elanco Description and Business Overview

Table 77. Elanco Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Elanco Endoparasiticide Product

Table 79. Elanco Recent Developments/Updates

Table 80. Zoetis Corporation Information

Table 81. Zoetis Description and Business Overview

Table 82. Zoetis Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Zoetis Endoparasiticide Product

Table 84. Zoetis Recent Developments/Updates

Table 85. Merck Corporation Information

Table 86. Merck Description and Business Overview

Table 87. Merck Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Merck Endoparasiticide Product

Table 89. Merck Recent Developments/Updates

Table 90. Virbac Corporation Information

Table 91. Virbac Description and Business Overview

Table 92. Virbac Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Virbac Endoparasiticide Product

Table 94. Virbac Recent Developments/Updates

Table 95. Novartis AG Corporation Information

Table 96. Novartis AG Description and Business Overview

Table 97. Novartis AG Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Novartis AG Endoparasiticide Product

Table 99. Novartis AG Recent Developments/Updates

Table 100. Ceva Sante Animlae Corporation Information

Table 101. Ceva Sante Animlae Description and Business Overview

Table 102. Ceva Sante Animlae Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Ceva Sante Animlae Endoparasiticide Product

Table 104. Ceva Sante Animlae Recent Developments/Updates

Table 105. Bayer AG Corporation Information

Table 106. Bayer AG Description and Business Overview

Table 107. Bayer AG Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Bayer AG Endoparasiticide Product

Table 109. Bayer AG Recent Developments/Updates

Table 110. Eli Lilly Corporation Information

Table 111. Eli Lilly Description and Business Overview

Table 112. Eli Lilly Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Eli Lilly Endoparasiticide Product

Table 114. Eli Lilly Recent Developments/Updates

Table 115. Vetoquinol Corporation Information

Table 116. Vetoquinol Description and Business Overview

Table 117. Vetoquinol Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Vetoquinol Endoparasiticide Product

Table 119. Vetoquinol Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Endoparasiticide Distributors List

Table 123. Endoparasiticide Customers List

Table 124. Endoparasiticide Market Trends

Table 125. Endoparasiticide Market Drivers

Table 126. Endoparasiticide Market Challenges

Table 127. Endoparasiticide Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Endoparasiticide

Figure 2. Global Endoparasiticide Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Endoparasiticide Market Share by Type in 2023 & 2030

Figure 4. Ear Tags Product Picture

Figure 5. Tablets Product Picture

Figure 6. Injectables Product Picture

Figure 7. Feed Additives Product Picture

Figure 8. Global Endoparasiticide Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Endoparasiticide Market Share by Application in 2023 & 2030

Figure 10. Veterinary Hospitals or Clinics

Figure 11. Animal Farms

Figure 12. Home Care Settings

Figure 13. Global Endoparasiticide Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Endoparasiticide Market Size (2019-2030) & (US$ Million)

Figure 15. Global Endoparasiticide Sales (2019-2030) & (K Units)

Figure 16. Global Endoparasiticide Average Price (US$/Unit) & (2019-2030)

Figure 17. Endoparasiticide Report Years Considered

Figure 18. Endoparasiticide Sales Share by Manufacturers in 2023

Figure 19. Global Endoparasiticide Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Endoparasiticide Players: Market Share by Revenue in 2023

Figure 21. Endoparasiticide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Endoparasiticide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Endoparasiticide Sales Market Share by Country (2019-2030)

Figure 24. North America Endoparasiticide Revenue Market Share by Country (2019-2030)

Figure 25. U.S. Endoparasiticide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Endoparasiticide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Endoparasiticide Sales Market Share by Country (2019-2030)

Figure 28. Europe Endoparasiticide Revenue Market Share by Country (2019-2030)

Figure 29. Germany Endoparasiticide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Endoparasiticide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Endoparasiticide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Endoparasiticide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Endoparasiticide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Endoparasiticide Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Endoparasiticide Revenue Market Share by Region (2019-2030)

Figure 36. China Endoparasiticide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Endoparasiticide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Endoparasiticide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Endoparasiticide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Endoparasiticide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Taiwan Endoparasiticide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Indonesia Endoparasiticide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Thailand Endoparasiticide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Malaysia Endoparasiticide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Philippines Endoparasiticide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Latin America Endoparasiticide Sales Market Share by Country (2019-2030)

Figure 47. Latin America Endoparasiticide Revenue Market Share by Country (2019-2030)

Figure 48. Mexico Endoparasiticide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Brazil Endoparasiticide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Argentina Endoparasiticide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Endoparasiticide Sales Market Share by Country (2019-2030)

Figure 52. Middle East & Africa Endoparasiticide Revenue Market Share by Country (2019-2030)

Figure 53. Turkey Endoparasiticide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Endoparasiticide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. UAE Endoparasiticide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Global Sales Market Share of Endoparasiticide by Type (2019-2030)

Figure 57. Global Revenue Market Share of Endoparasiticide by Type (2019-2030)

Figure 58. Global Endoparasiticide Price (US$/Unit) by Type (2019-2030)

Figure 59. Global Sales Market Share of Endoparasiticide by Application (2019-2030)

Figure 60. Global Revenue Market Share of Endoparasiticide by Application (2019-2030)

Figure 61. Global Endoparasiticide Price (US$/Unit) by Application (2019-2030)

Figure 62. Endoparasiticide Value Chain

Figure 63. Endoparasiticide Production Process

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Distributors Profiles

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Bearberry Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-37P7585

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Ophthalmic Steroids Drug Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-37N7580

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Autoimmune Disorder Drug Delivery Device Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-0K8018

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Metronidazole API Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-18R12687

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions